Regeneron
Regeneron is a fully integrated biopharmaceutical company with a global reach, known for its diverse product portfolio and a strong focus on technology-driven drug discovery and development across multiple therapeutic areas.
Company Overview
Regeneron operates as a fully integrated biopharma company with global reach. The company has a diverse product portfolio and resources rivaling those of large pharmaceutical firms, yet maintains a science-driven entrepreneurial culture. Engaged in numerous collaborations, Regeneron augments and expands its extensive in-house capabilities.
Technology Platforms
Regeneron leverages advanced technology platforms such as VelociSuite® to enhance and accelerate drug discovery and development. These cutting-edge tools are designed to streamline the development process, ensuring efficiency and effectiveness in bringing new therapies to market.
Therapeutic Areas
Regeneron focuses on a broad range of therapeutic areas. These include Ophthalmology, Hematology, Oncology, Immunology & Inflammation, Cardiovascular and Metabolic Diseases, and Infectious Disease. This wide focus allows the company to address diverse medical needs and expand its impact on global health.
Genetics Research
The company operates the Regeneron Genetics Center®, which is one of the most comprehensive genetic databases in the world. This facility plays a crucial role in the company’s drug development efforts, enabling deeper understanding and targeted approaches in addressing genetic factors in diseases.
Pipeline and Collaborations
Regeneron boasts a robust pipeline of over 30 investigational medicines. These include treatments across various therapeutic areas. The company also provides access to its technologies and medicines for third-party studies, extending the impact of its scientific advancements beyond its own product portfolio.